Technical Analysis for ISEE - IVERIC bio, Inc.

Grade Last Price % Change Price Change
grade D 1.18 8.26% 0.09
ISEE closed up 8.26 percent on Monday, August 19, 2019, on 66 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ISEE trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 8.26%
Below Lower BB Weakness 8.26%
Down 3 Days in a Row Weakness 8.26%
Down 4 Days in a Row Weakness 8.26%

Older signals for ISEE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
IVERIC bio, Inc., formerly Ophthotech Corporation, is a biopharmaceutical company. The Company is focused on the discovering and developing of novel gene therapy solutions to treat orphan inherited retinal diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness. The Company’s BEST1 gene encodes a multifunctional protein known as bestrophin1, that regulates ion transport and intracellular calcium signaling in retina cells and helps maintain homeostasis in the sub retinal space between photoreceptors and the retinal pigment epithelial (RPE) cells. Its IC-200 is a mutation independent gene therapy, delivered by an AAV2 vector.
Biopharmaceutical Diseases Emerging Technologies Gene Therapy Ophthalmology Macular Degeneration Age Related Macular Degeneration Vision Blindness Disorder Retina Retinal Diseases Bestrophin 1 Gene Therapy Of The Human Retina Macula Of Retina Visual System
Is ISEE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.6
52 Week Low 1.02
Average Volume 85,878
200-Day Moving Average 1.4239
50-Day Moving Average 1.2189
20-Day Moving Average 1.162
10-Day Moving Average 1.145
Average True Range 0.064
ADX 18.44
+DI 13.6445
-DI 17.6865
Chandelier Exit (Long, 3 ATRs ) 1.058
Chandelier Exit (Short, 3 ATRs ) 1.262
Upper Bollinger Band 1.2282
Lower Bollinger Band 1.0958
Percent B (%b) 0.64
BandWidth 11.394148
MACD Line -0.0262
MACD Signal Line -0.0274
MACD Histogram 0.0012
Fundamentals Value
Market Cap 42.41 Million
Num Shares 35.9 Million
EPS -5.39
Price-to-Earnings (P/E) Ratio -0.22
Price-to-Sales 8.05
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.32
Resistance 3 (R3) 1.31 1.24 1.30
Resistance 2 (R2) 1.24 1.21 1.25 1.29
Resistance 1 (R1) 1.21 1.18 1.23 1.23 1.28
Pivot Point 1.15 1.15 1.16 1.16 1.15
Support 1 (S1) 1.12 1.11 1.13 1.13 1.08
Support 2 (S2) 1.05 1.09 1.06 1.07
Support 3 (S3) 1.02 1.05 1.06
Support 4 (S4) 1.04